Preventing herpes simplex virus in the newborn

Clinics in Perinatology

Volumn 41, Issue 4, 2014, Pages 945-955

  Pinninti, Swetha G ^a   Kimberlin, David W ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Acyclovir; Antiviral therapy; Genital herpes; HSV; PCR

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; GLYCOPROTEIN D; HERPES SIMPLEX VACCINE; PLACEBO; VALACICLOVIR; VIRUS DNA;

CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE TRANSMISSION; EARLY DIAGNOSIS; ENVIRONMENTAL EXPOSURE; EYE DISEASE; FETAL SCALP ELECTRODE; GENITAL HERPES; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; MEMBRANE RUPTURE; MORBIDITY; MORTALITY; MOUTH DISEASE; NEWBORN CARE; POLYMERASE CHAIN REACTION; PREGNANCY; PREVENTIVE MEDICINE; PROGNOSIS; RECURRENT INFECTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEROPREVALENCE; SKIN DISEASE; UNITED STATES; VAGINAL DELIVERY; VIRUS CULTURE; VIRUS TRANSMISSION; CEREBROSPINAL FLUID; CESAREAN SECTION; ENCEPHALITIS, HERPES SIMPLEX; FEMALE; GENETICS; NEWBORN; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL; SIMPLEXVIRUS; TRANSMISSION; VERTICAL TRANSMISSION;

ANTIVIRAL AGENTS; CESAREAN SECTION; DNA, VIRAL; ENCEPHALITIS, HERPES SIMPLEX; FEMALE; HERPES SIMPLEX; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SIMPLEXVIRUS;

EID: 84911005086     PISSN: 00955108     EISSN: 15579840     Source Type: Journal    
DOI: 10.1016/j.clp.2014.08.012     Document Type: Review

References (36)

1. Kulhanjian J.A., Soroush V., Au D.S., et al. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. NEngl J Med 1992, 326(14):916-920.
2. Whitley R.J., Corey L., Arvin A., et al. Changing presentation of herpes simplex virus infection in neonates. JInfect Dis 1988, 158(1):109-116.
3. Brown Z.A., Selke S., Zeh J., et al. The acquisition of herpes simplex virus during pregnancy. NEngl J Med 1997, 337(8):509-515.
4. Sheffield J.S., Hill J.B., Hollier L.M., et al. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial. Obstet Gynecol 2006, 108(1):141-147.
5. Watts D.H., Brown Z.A., Money D., et al. Adouble-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery. Am J Obstet Gynecol 2003, 188(3):836-843.
6. Brown Z.A., Benedetti J., Ashley R., et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. NEngl J Med 1991, 324(18):1247-1252.
7. Arvin A.M., Hensleigh P.A., Prober C.G., et al. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. NEngl J Med 1986, 315(13):796-800.
8. Vontver L.A., Hickok D.E., Brown Z., et al. Recurrent genital herpes simplex virus infection in pregnancy: infant outcome and frequency of asymptomatic recurrences. Am J Obstet Gynecol 1982, 143(1):75-84.
9. Sullender W.M., Yasukawa L.L., Schwartz M., et al. Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes. JInfect Dis 1988, 157(1):164-171.
10. Brown Z.A., Wald A., Morrow R.A., et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003, 289(2):203-209.
11. Kimberlin D.W. Neonatal herpes simplex infection. Clin Microbiol Rev 2004, 17(1):1-13.
12. ACOG Committee on Practice Bulletins ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 82 June 2007. Management of herpes in pregnancy. Obstet Gynecol 2007, 109(6):1489-1498.
13. Peng J., Krause P.J., Kresch M. Neonatal herpes simplex virus infection after cesarean section with intact amniotic membranes. JPerinatol 1996, 16(5):397-399.
14. Nahmias A.J., Josey W.E., Naib Z.M., et al. Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol 1971, 110(6):825-837.
15. Kaye E.M., Dooling E.C. Neonatal herpes simplex meningoencephalitis associated with fetal monitor scalp electrodes. Neurology 1981, 31(8):1045-1047.
16. Whitley R.J., Nahmias A.J., Soong S.J., et al. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics 1980, 66(4):495-501.
17. Whitley R., Arvin A., Prober C., et al. Acontrolled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. NEngl J Med 1991, 324(7):444-449.
18. Whitley R., Arvin A., Prober C., et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. NEngl J Med 1991, 324(7):450-454.
19. Kimberlin D.W., Lin C.Y., Jacobs R.F., et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001, 108(2):230-238.
20. Kimberlin D.W., Lin C.Y., Jacobs R.F., et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001, 108(2):223-229.
21. American Academy of Pediatrics Herpes simplex. Red book: 2012 report of the Committee on Infectious Diseases 2012, 398-408. American Academy of Pediatrics, Elk Grove Village (IL). 29th edition. L. Pickering, C. Baker, D. Kimberlin (Eds.).
22. Diamond C., Mohan K., Hobson A., et al. Viremia in neonatal herpes simplex virus infections. Pediatr Infect Dis J 1999, 18(6):487-489.
23. Kimberlin D.W., Lakeman F.D., Arvin A.M., et al. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. JInfect Dis 1996, 174(6):1162-1167.
24. Kimura H., Futamura M., Kito H., et al. Detection of viral DNA in neonatal herpes simplex virus infections: frequent and prolonged presence in serum and cerebrospinal fluid. JInfect Dis 1991, 164(2):289-293.
25. Malm G., Forsgren M. Neonatal herpes simplex virus infections: HSV DNA in cerebrospinal fluid and serum. Arch Dis Child Fetal Neonatal Ed 1999, 81(1):F24-29.
26. Lewensohn-Fuchs I., Osterwall P., Forsgren M., et al. Detection of herpes simplex virus DNA in dried blood spots making a retrospective diagnosis possible. JClin Virol 2003, 26(1):39-48.
27. Kimberlin D.W., Whitley R.J., Wan W., et al. Oral acyclovir suppression and neurodevelopment after neonatal herpes. NEngl J Med 2011, 365(14):1284-1292.
28. Kimberlin D., Powell D., Gruber W., et al. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dis J 1996, 15(3):247-254.
29. Kimberlin D.W., Baley J., Committee on Infectious Diseases, Committee on Fetus and Newborn Guidance on management of asymptomatic neonates born to women with active genital herpes lesions. Pediatrics 2013, 131(2):383-386.
30. Roberts S.W., Cox S.M., Dax J., et al. Genital herpes during pregnancy: no lesions, no cesarean. Obstet Gynecol 1995, 85(2):261-264.
31. Pinninti S.G., Angara R., Feja K.N., et al. Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: a multicenter case series. JPediatr 2012, 161(1):134-138.e1-3.
32. Stanberry L.R., Spruance S.L., Cunningham A.L., et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. NEngl J Med 2002, 347(21):1652-1661.
33. Belshe R.B., Leone P.A., Bernstein D.I., et al. Efficacy results of a trial of a herpes simplex vaccine. NEngl J Med 2012, 366(1):34-43.
34. Brown Z.A., Gardella C., Wald A., et al. Genital herpes complicating pregnancy. Obstet Gynecol 2005, 106(4):845-856.
35. Corey L., Wald A. Maternal and neonatal herpes simplex virus infections. NEngl J Med 2009, 361(14):1376-1385.
36. Centers for Disease Control and Prevention (CDC) Neonatal herpes simplex virus infection following Jewish ritual circumcisions that included direct orogenital suction - New York City, 2000-2011. MMWR Morb Mortal Wkly Rep 2012, 61:405-409.